The effects of cachexia and related components on pulmonary functions in patients with COPD

Tuberkuloz ve Toraks

Volumn 57, Issue 3, 2009, Pages 298-305

  Görek Dilektaşli, Asli ^a   Ulubay, Gaye ^a,b   Bayraktar, Nilüfer ^a   Eminsoy, Irem ^a   Öner Eyüboǧlu, Füsun ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b Baskent University Hospital ^*  (Turkey)

Author keywords

Cachexia; Chronic obstructive pulmonary disease; Pulmonary function tests; Resting energy expenditure; Tumor necrosis factor alpha

Indexed keywords

ALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

AGED; AIRWAY; ALBUMIN BLOOD LEVEL; ARTERIAL OXYGEN TENSION; ARTICLE; BODY MASS; CACHEXIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MALE; MALNUTRITION; WEIGHT REDUCTION;

AGED; ANTHROPOMETRY; BASAL METABOLISM; BLOOD GAS ANALYSIS; CACHEXIA; FEMALE; HUMANS; LUNG; MALE; MALNUTRITION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349758329     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Schols AM, Mostert R, Soeters PB, et al. Nutritional state and exercise performance in patients with chronic obstructive lung disease. Thorax 1989; 44: 937-941 (Pubitemid 19281536)
2. Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1856-1861 (Pubitemid 30004687)
3. Pitsiou G, Kyriazis G, Hatzizisi O, et al. Tumor necrosis factor-alpha levels, weight loss and tissue oxygenation in chronic obstructive pulmonary disease. Respir Med 2002; 96: 594-598
4. Karadag F, Karul AB, Cildag O, et al. Determinants of BMI in patients with COPD. Respirology 2004; 9: 70-75
5. Di Francia MD, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: 1453-1455 (Pubitemid 24356667)
6. Takabatake N, Nakamura H, Abe S, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1179-1184 (Pubitemid 30243827)
7. De Godoy I, Donahoe M, Calhoun WJ, et al. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 1996; 153: 633-637 (Pubitemid 26051340)
8. Donahoe M, Rogers RM. Nutritional assessment and support in chronic obstructive pulmonary disease. Clin Chest Med 1990; 11: 487-504. (Pubitemid 20257785)
9. Schols AM, Soeters PB, Mostert R, et al. Energy balance in chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 143: 1248-1252
10. Tang NL, Chung ML, Elia M, et al. Total daily energy expenditure in wasted chronic obstructive pulmonary disease patients. Eur J Clin Nutr 2002; 56: 282-287 (Pubitemid 34413820)
11. Nguyen LT, Bedu M, Caillaud D, et al. Increased resting energy expenditure is related to plasma TNF-alpha concentration in stable COPD patients. Clin Nutr 1999; 18: 269-274 (Pubitemid 29527735)
12. Ryan CF, Road JD, Buckley PA, et al. Energy balance in stable malnourished patients with chronic obstructive pulmonary disease. Chest 1993; 103: 1038-1044 (Pubitemid 23110267)
13. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease: The National Institutes of Health Intermittent Positive Pressure Breathing Trial. Am Rev Respir Dis 1989; 139: 1435-1438
14. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511-522
15. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338
16. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management of chronic obstructive pulmonary disease. NHLBI/WHO-Workshop Report 2006. www.goldcopd.com/workshop/index.html. Date last updated: November 2006.
17. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol (Lond) 1949; 109: 1-9.
18. De Boer WI. Cytokines and therapy in COPD. A promising combination? Chest 2002; 121: 209-218
19. Calikoglu M, Sahin G, Unlu C, et al. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters. Respiration 2004; 71: 45-50. (Pubitemid 38223765)
20. Franciosi LG, Page CP, Celli BR, et al. Markers of disease severity in chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2006; 19: 189-199
21. Richter J, Andersson T, Olsson I. Effect of tumor necrosis factor and granulocyte/macrophage colony-stimulating factor on neutrophil degranulation. J Immunol 1989; 142: 3199-3205 (Pubitemid 19129943)
22. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J 2001; (Suppl 34): 50-59
23. Hart N, Cramer D, Ward SP, et al. Effect of pattern and severity of respiratory muscle weakness on carbon monoxide gas transfer and lung volumes. Eur Respir J 2002; 20: 996-1002. (Pubitemid 35175140)
24. Blakemore WS, Forster RE, Morton JW, Ogilvie CM. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest 1957; 36: 1-17.
25. Wedzicha JA, Cotes PM, Empey DW, et al. Serum immunoreactive erythropoietin in hypoxic lung disease with and without polycythaemia. Clin Sci (Lond) 1985; 69: 413-422 (Pubitemid 15003813)
26. Yoneda T, Yoshikawa M, Fu A, et al. Plasma levels of amino acids and hypermetabolism in patients with chronic obstructive pulmonary disease. Nutr 2001; 17: 95-99 (Pubitemid 32178284)